These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15372744)

  • 1. Endogenous inhibitors of angiogenesis.
    Folkman J
    Harvey Lect; 1996-1997; 92():65-82. PubMed ID: 15372744
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticancer drug targets: approaching angiogenesis.
    Keshet E; Ben-Sasson SA
    J Clin Invest; 1999 Dec; 104(11):1497-501. PubMed ID: 10587512
    [No Abstract]   [Full Text] [Related]  

  • 3. [Research advancement of endogenous angiogenesis inhibitors].
    Wu JX; Xu BL; Huang WL
    Ai Zheng; 2005 Mar; 24(3):376-84. PubMed ID: 15757547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic prospects of angiogenesis inhibitors in cancerology].
    Bout JC; Soncin F; Vandenbunder B
    Rev Mal Respir; 1999 Nov; 16(5):854-5. PubMed ID: 10612161
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiogenesis and surgery: from mice to man.
    Drixler TA; Voest EE; van Vroonhoven TJ; Borel Rinkes IH
    Eur J Surg; 2000 Jun; 166(6):435-46. PubMed ID: 10890539
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular mechanisms and therapeutic development of angiogenesis inhibitors.
    Cao Y
    Adv Cancer Res; 2008; 100():113-31. PubMed ID: 18620094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of angiogenesis inhibitory combination therapies for treatment of renal cell carcinoma].
    Bartsch G; Eggert K; Soker S; Fiedler W; Laack E; Volkmer BG; Gschwend J; Bokemeyer C; Hautmann R; Schuch G
    Urologe A; 2007 Sep; 46(9):1289-90. PubMed ID: 17624513
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.
    Folkman J
    Exp Cell Res; 2006 Mar; 312(5):594-607. PubMed ID: 16376330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of selected patents for cancer therapy targeting tumor angiogenesis.
    Kirstein MN; Moore MM; Dudek AZ
    Recent Pat Anticancer Drug Discov; 2006 Jun; 1(2):153-61. PubMed ID: 18221033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The story of angiostatin and how controversy is useful in science].
    Kurjak A
    Acta Med Croatica; 2003; 57(2):145-8. PubMed ID: 12879695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for the functions of endogenous angiogenesis inhibitors.
    Grant MA; Kalluri R
    Cold Spring Harb Symp Quant Biol; 2005; 70():399-410. PubMed ID: 16869777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endostatin--light on the treatment of cancer in mice].
    Porkka K
    Duodecim; 1997; 113(22):2241-3. PubMed ID: 10892128
    [No Abstract]   [Full Text] [Related]  

  • 13. A cancer therapy resistant to resistance.
    Kerbel RS
    Nature; 1997 Nov; 390(6658):335-6. PubMed ID: 9389468
    [No Abstract]   [Full Text] [Related]  

  • 14. [Progress in the lung cancer therapy with angiogenesis inhibitors].
    Bai C; Ma T
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):306-7. PubMed ID: 11326959
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiogenesis and cancer: recent advances.
    Cáceres W; González S
    P R Health Sci J; 2003 Jun; 22(2):149-51. PubMed ID: 12866139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Closing in on cancer.
    Park A
    Time; 2001 May; 157(20):60, 62. PubMed ID: 11383110
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel agents target existing tumor vasculature.
    Expert Rev Anticancer Ther; 2010 Mar; 10(3):303. PubMed ID: 20235388
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiogenesis: the unifying concept in cancer?
    Saphir A
    J Natl Cancer Inst; 1997 Nov; 89(22):1658-9. PubMed ID: 9390530
    [No Abstract]   [Full Text] [Related]  

  • 19. Angiogenesis as a therapeutic target.
    Ferrara N; Kerbel RS
    Nature; 2005 Dec; 438(7070):967-74. PubMed ID: 16355214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer.
    Roukos DH; Tzakos A; Zografos G
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1413-6. PubMed ID: 19828000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.